Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. 21 Απρ 2023 · Of the pathogenic Klebsiella species, K. pneumoniae is the most prevalent and clinically important. Infections with K. pneumoniae are usually hospital-acquired and occur primarily in patients with impaired host defenses.

  2. Until very recently, the pipeline of new drugs for the treatment of multidrug-resistant gram-negative pathogens had been described as “dry”. However, a number of new drugs with in vitro activity against multidrug-resistant strains of K. pneumoniae are now in development.

  3. 2 Ιουν 2022 · Doctors or healthcare professionals typically treat K. pneumoniae infections with antibiotics, but some strains have developed drug resistance. These infections are very difficult to treat...

  4. 18 Αυγ 2022 · Summary. We retrospectively analyzed published data on the use and outcomes of antimicrobial therapy for K. pneumoniae infections. We discussed plazomicin, eravacycline, fosfomycin, tigecycline, and polymyxin as prevalent therapeutic options.

  5. 20 Ιουλ 2023 · Objectives: Describe the pathophysiology of Klebsiella. Identify the most common cause of hospital-acquired pneumonia in the United States. Recall patients most likely to get Klebsiella pneumonia. Review the evaluation and treatment of patients with Klebsiella pneumonia and the interprofessional team's role in managing patients with this condition.

  6. 19 Φεβ 2020 · When a person develops pneumonia from K. pneumoniae, doctors typically recommend a 2-week treatment with third- or fourth-generation cephalosporin, a fluoroquinolone, or one of these antibiotics...

  7. treatments available. However, there are still some options which can treat CRKP infections, including antibiotics like fosfomycin, aminoglycosides, tigecycline and carbapenems. • It is important to follow your doctor’s advice, whatever treatment plan they advise you to follow. How are K. pneumoniae infections treated? Limiting physical ...

  1. Γίνεται επίσης αναζήτηση για